CDC Antimicrobial Resistance Investment Map / CDC
Capital Type
Government / Public Funder
Investment Size
Varies by award
Geographic Scope
US
Return Model
Non-Dilutive
Stage Focus
Implementation, Surveillance, Innovation research
Modality Focus
Surveillance, Public health, Diagnostics
Overview
CDC funds surveillance, laboratories, and selected innovative research projects to respond to antimicrobial resistance across the public-health system.
Portfolio and Signals
Important for public-health AMR innovation and implementation pathways, though less founder-oriented than NIH or BARDA.
Access and Engagement
Access is typically through public-health programs, cooperative agreements, and federal funding opportunities.
Notable AMR Examples / Programs
FY2025 AR investment map and innovation projects
Stay Updated
Stay connected so that you don't miss the latest AMR insights and updates.
